Glenmark Pharmaceuticals Inc., USA: Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glen
Read the official notice at FDA (drug) →
Get alerts for Glenmark Pharmaceuticals
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Glenmark Pharmaceuticals Inc., USA
- Product
- Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
- Reason / hazard
- Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the United States
- Recall initiated
- 2025-12-30
- Code info
- Lot #: 19251311, Exp Date April 2027
- Product quantity
- 96,948 packs
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Elmwood Park
- State
- NJ
- Country
- United States
- Event id
- 98233
Free daily digest + "My products" watchlist